Show simple item record

dc.contributor.authorHemmerling, A
dc.contributor.authorHarrison, WG
dc.contributor.authorBrown, JM
dc.contributor.authorMoscicki, B
dc.contributor.authorOziemkowska, M
dc.contributor.authorBukusi, EA
dc.contributor.authorCohen, CR
dc.date.accessioned2013-06-12T12:31:44Z
dc.date.available2013-06-12T12:31:44Z
dc.date.issued2012
dc.identifier.citationSex Transm Dis. 2012 Sep;39(9):710-2.en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/22902667
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/32310
dc.description.abstractDye staining of applicators has been shown to be a reliable and objective method to test vaginal insertion in clinical microbicide trials, but different plastics, dyes, and product formulations may impact the accuracy of this method. Reportedly used applicators returned from 3 clinical trials were stained with 1% trypan blue. In a phase 1 study (VivaGel), using gel-filled HTI polypropylene applicators, 1271 (97%) of applicators stained positive. In a phase 1 and a phase 2a study (LACTIN-V) using linear low-density polyethylene applicators to deliver a dry powder formulation, 57 (95%) and 135 (86%) tested positive, respectively. Dye staining of vaginal applicators is an objective low-cost measure suitable for low-resource settings.en
dc.language.isoenen
dc.titleTrypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulationsen
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record